| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0968-0896(03)00051-8 |
| P698 | PubMed publication ID | 12670657 |
| P50 | author | Tsai-Kun Li | Q60595510 |
| P2093 | author name string | Angela Liu | |
| Jin-Ming Yang | |||
| Leroy F Liu | |||
| Edmond J LaVoie | |||
| Abhijit Ray | |||
| Alexander L Ruchelman | |||
| Xiao Hua Wu | |||
| Sudhir K Singh | |||
| P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model | Q26778456 | ||
| Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability | Q29617252 | ||
| Substituted benz[a]acridines and benz[c]acridines as mammalian topoisomerase poisons | Q31402527 | ||
| Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. | Q31856730 | ||
| Mechanisms of resistance to camptothecins. | Q34149115 | ||
| DNA topoisomerase poisons as antitumor drugs | Q38286727 | ||
| DNA topoisomerases: essential enzymes and lethal targets | Q40678987 | ||
| A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days | Q40731233 | ||
| Novel angular benzophenazines: dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents | Q40755472 | ||
| BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. | Q40863719 | ||
| Substituted 2,5'-Bi-1H-benzimidazoles: topoisomerase I inhibition and cytotoxicity | Q41227295 | ||
| Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors | Q41301752 | ||
| Drug resistance mechanisms of topoisomerase I drugs. | Q41315175 | ||
| Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus | Q43499508 | ||
| Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation | Q43547718 | ||
| Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model | Q43831933 | ||
| 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives | Q48150760 | ||
| Synthesis and evaluation of new 6-amino- substituted benzo[c]phenanthridine derivatives | Q63369519 | ||
| Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II | Q64390546 | ||
| Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives | Q67507590 | ||
| DNA topoisomerases | Q70095180 | ||
| Synthesis and hypotensive properties of new 4-aminoquinolines | Q70589031 | ||
| Ethyl substitution at the 7 position extends the half-life of 10-hydroxycamptothecin in the presence of human serum albumin | Q72889122 | ||
| Preferential binding of the carboxylate form of camptothecin by human serum albumin | Q72917829 | ||
| Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435 | Q78408466 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytotoxicity | Q246181 |
| P304 | page(s) | 2061-2073 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
| P1476 | title | 5H-Dibenzo[c,h]1,6-naphthyridin-6-ones: novel topoisomerase I-targeting anticancer agents with potent cytotoxic activity | |
| P478 | volume | 11 |
| Q37323423 | 11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents |
| Q37363598 | 12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents |
| Q42387483 | 2,2-Dimethyl-5-(1-naphthyl-amino-methyl-ene)-1,3-dioxane-4,6-dione |
| Q34266526 | 2,2-Dimethyl-5-(2-naphthyl-amino-methyl-ene)-1,3-dioxane-4,6-dione |
| Q41887326 | 2,2-Dimethyl-5-[(3-nitro-anilino)methyl-ene]-1,3-dioxane-4,6-dione |
| Q41878533 | 2,2-Dimethyl-5-[(pyridin-2-yl-amino)-methyl-idene]-1,3-dioxane-4,6-dione |
| Q42282612 | 2,9-Dimethyl-7-phenyl-N-(4-methyl-phen-yl)dibenzo[b,h][1,6]naphthyridin-6-amine |
| Q42388106 | 2-{4-[(2,2-Dimethyl-4,6-dioxo-1,3-dioxan-5-yl-idene)methyl-amino]phen-yl}acetonitrile |
| Q41808325 | 5-(4-Bromo-anilinomethyl-ene)-2,2-dimethyl-1,3-dioxane-4,6-dione |
| Q42388547 | 5-(4-Chloro-anilinomethyl-ene)-2,2-dimethyl-1,3-dioxane-4,6-dione |
| Q42388057 | 5-[(3,4-Dimethoxy-benzyl)-aminomethyl-ene]-2,2-dimethyl-1,3-dioxane-4,6-dione |
| Q42387767 | 5-[(4-Acetyl-phenyl)-aminomethyl-ene]-2,2-dimethyl-1,3-dioxane-4,6-dione |
| Q47610619 | 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-targeting agents: influence of structure on the ternary cleavable complex formation |
| Q47315353 | A support vector machine classification model for benzo[c]phenathridine analogues with toposiomerase-I inhibitory activity. |
| Q42115654 | Benzoquinoline amines - Key intermediates for the synthesis of angular and linear dinaphthonaphthyridines |
| Q36017647 | Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation |
| Q85113018 | Effect of specific solute-solvent interaction and electron donor-acceptor substituents of novel pyrazolo naphthyridines on fluorescence |
| Q43649721 | Highly efficient construction of pentacyclic benzo[b]indeno-[1,2,3-de][1,8]naphthyridine derivatives via four-component domino reaction |
| Q39289157 | Microscopic Modes and Free Energies for Topoisomerase I-DNA Covalent Complex Binding with Non-campothecin Inhibitors by Molecular Docking and Dynamics Simulations |
| Q37396799 | Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide |
| Q37363590 | Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c,h][1,6]naphthyridines as novel topoisomerase I-targeting antitumor agents |
| Q33263160 | Topoisomerase I-mediated DNA cleavage induced by the minor groove-directed binding of bibenzimidazoles to a distal site |
| Q38101143 | Topoisomerase inhibitors as anticancer agents: a patent update |
| Q38968355 | Topoisomerases: Resistance versus Sensitivity, How Far We Can Go? |
| Q50196642 | tert-Butyl nitrite (TBN) as the N atom source for the synthesis of substituted cinnolines with 2-vinylanilines and a relevant mechanism was studied. |
Search more.